Why spirits slowdown could prompt majors to diversify
Just Drinks columnist Richard Woodard sets out why Suntory’s decision to spend $1.6bn on a pharma business in Japan might be a sign of things to come in spirits.
Just Drinks columnist Richard Woodard sets out why Suntory’s decision to spend $1.6bn on a pharma business in Japan might be a sign of things to come in spirits.